Dr. Khozin is a physician-data scientist focused on building solutions at the intersection of biomedicine, healthcare and connected technologies. A thoracic oncologist, Dr. Khozin currently serves as associate director of the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA), leading the Center’s bioinformatics initiatives. He is also director of Information Exchange and Data Transformation (INFORMED; www.fda.gov/INFORMED), the FDA’s first data science and technology incubator for collaborative regulatory science research focused on supporting innovations that enhance the agency’s mission of promotion and protection of public health. The research portfolio of INFORMED includes investigations into the use of real-world data for clinical evidence generation and decentralized clinical trials, examination of the utility of biosensors and the internet of things to quantify intrinsic and extrinsic (e.g., environmental) factors influencing the patient’s experience, development of applications for machine learning and artificial intelligence in regulatory science and drug development, and testing the utility of decentralized technologies such as blockchain to enable secure exchange of health data at scale.
Previously, Dr. Khozin owned and managed a multidisciplinary healthcare delivery network in New York City as a practicing physician and was an entrepreneur specializing in building health information technology systems with telemedicine, point-of-care data visualization and advanced analytics capabilities.